Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering - PubMed (original) (raw)

Review

. 2007 May 30;59(4-5):339-59.

doi: 10.1016/j.addr.2007.03.016. Epub 2007 Apr 12.

Affiliations

• PMID: 17499384
• DOI: 10.1016/j.addr.2007.03.016

Review

Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering

Soo-Hong Lee et al. Adv Drug Deliv Rev. 2007.

Abstract

Regeneration of bone and cartilage defects can be accelerated by localized delivery of appropriate growth factors incorporated within biodegradable carriers. The carrier essentially allows the impregnated growth factor to release at a desirable rate and concentration, and to linger at injury sites for a sufficient time to recruit progenitors and stimulate tissue healing processes. In addition, the carrier can be formulated to have particular structure to facilitate cellular infiltration and growth. In this review, we present a summary of growth factor delivery carrier systems for bone and cartilage tissue engineering. Firstly, we describe a list of growth factors implicated in repair and regeneration of bone and cartilage by addressing their biological effects at different stages of the healing process. General requirements for localized growth factor delivery carriers are then discussed. We also provide selective examples of material types (natural and synthetic polymers, inorganic materials, and their composites) and fabricated forms of the carrier (porous scaffolds, microparticles, and hydrogels), highlighting the dose-dependent efficacy, release kinetics, animal models, and restored tissue types. Extensive discussion on issues involving currently investigated carriers for bone and cartilage tissue engineering approaches may illustrate future paths toward the development of an ideal growth factor delivery system.

PubMed Disclaimer

Similar articles

• Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.
  Chung HJ, Park TG. Chung HJ, et al. Adv Drug Deliv Rev. 2007 May 30;59(4-5):249-62. doi: 10.1016/j.addr.2007.03.015. Epub 2007 Apr 10. Adv Drug Deliv Rev. 2007. PMID: 17482310 Review.
• Matrices and scaffolds for protein delivery in tissue engineering.
  Tessmar JK, Göpferich AM. Tessmar JK, et al. Adv Drug Deliv Rev. 2007 May 30;59(4-5):274-91. doi: 10.1016/j.addr.2007.03.020. Epub 2007 May 3. Adv Drug Deliv Rev. 2007. PMID: 17544542 Review.
• Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering.
  Habraken WJ, Wolke JG, Jansen JA. Habraken WJ, et al. Adv Drug Deliv Rev. 2007 May 30;59(4-5):234-48. doi: 10.1016/j.addr.2007.03.011. Epub 2007 Apr 6. Adv Drug Deliv Rev. 2007. PMID: 17478007 Review.
• Injectable matrices and scaffolds for drug delivery in tissue engineering.
  Kretlow JD, Klouda L, Mikos AG. Kretlow JD, et al. Adv Drug Deliv Rev. 2007 May 30;59(4-5):263-73. doi: 10.1016/j.addr.2007.03.013. Epub 2007 Apr 6. Adv Drug Deliv Rev. 2007. PMID: 17507111 Review.
• Delivery of bone morphogenetic proteins for orthopedic tissue regeneration.
  Seeherman H, Wozney JM. Seeherman H, et al. Cytokine Growth Factor Rev. 2005 Jun;16(3):329-45. doi: 10.1016/j.cytogfr.2005.05.001. Cytokine Growth Factor Rev. 2005. PMID: 15936978 Review.

Cited by

• Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.
  Hashemi ZS, Moghadam MF, Soleimani M. Hashemi ZS, et al. In Vitro Cell Dev Biol Anim. 2015 May;51(5):495-506. doi: 10.1007/s11626-014-9854-y. Epub 2014 Dec 25. In Vitro Cell Dev Biol Anim. 2015. PMID: 25539863
• Extracellular Calcium Modulates Chondrogenic and Osteogenic Differentiation of Human Adipose-Derived Stem Cells: A Novel Approach for Osteochondral Tissue Engineering Using a Single Stem Cell Source.
  Mellor LF, Mohiti-Asli M, Williams J, Kannan A, Dent MR, Guilak F, Loboa EG. Mellor LF, et al. Tissue Eng Part A. 2015 Sep;21(17-18):2323-33. doi: 10.1089/ten.TEA.2014.0572. Epub 2015 Jul 13. Tissue Eng Part A. 2015. PMID: 26035347 Free PMC article.
• Strategies for controlled delivery of growth factors and cells for bone regeneration.
  Vo TN, Kasper FK, Mikos AG. Vo TN, et al. Adv Drug Deliv Rev. 2012 Sep;64(12):1292-309. doi: 10.1016/j.addr.2012.01.016. Epub 2012 Feb 4. Adv Drug Deliv Rev. 2012. PMID: 22342771 Free PMC article. Review.
• Bone Morphogenic Protein 2-Loaded Porous Silicon Carriers for Osteoinductive Implants.
  Rosenberg M, Shilo D, Galperin L, Capucha T, Tarabieh K, Rachmiel A, Segal E. Rosenberg M, et al. Pharmaceutics. 2019 Nov 12;11(11):602. doi: 10.3390/pharmaceutics11110602. Pharmaceutics. 2019. PMID: 31726775 Free PMC article.
• Development of a Three-Dimensional Bioengineered Platform for Articular Cartilage Regeneration.
  Rubí-Sans G, Recha-Sancho L, Pérez-Amodio S, Mateos-Timoneda MÁ, Semino CE, Engel E. Rubí-Sans G, et al. Biomolecules. 2019 Dec 28;10(1):52. doi: 10.3390/biom10010052. Biomolecules. 2019. PMID: 31905668 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database